HA
TMO icon

Herold Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Herold Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-378
Closed -$234K – 281
2024
Q3 		$234K Hold
378
– – 0.05% 245
2024
Q2 		$209K Hold
378
– – 0.05% 247
2024
Q1 		$220K Sell
378
-1,351
-78% -$758K 0.05% 245
2023
Q4 		$918K Buy
1,729
+240
+16% +$116K 0.25% 114
2023
Q3 		$754K Buy
1,489
+279
+23% +$149K 0.23% 124
2023
Q2 		$631K Buy
1,210
+164
+16% +$88.5K 0.19% 132
2023
Q1 		$603K Buy
1,046
+611
+140% +$344K 0.21% 121
2022
Q4 		$240K Hold
435
– – 0.1% 181
2022
Q3 		$220K Hold
435
– – 0.11% 173
2022
Q2 		$236K Buy
435
+65
+18% +$35.8K 0.11% 178
2022
Q1 		$219K Buy
+370
New +$213K 0.08% 187

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return